Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis
Abroad (travel likely)RecruitingPHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
SARS-Cov-2 Induced Pulmonary Fibrosis
Locations
- Pneumologie, Paris, France